ITERUM THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.55 USD | -2.52% |
|
+1.31% | -21.32% |
| 29/04 | Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem | CI |
| 28/03 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 1.670 | 2.300 | 2.300 |
| Spread/Res. | -7.19% | -32.61% | -32.61% |
| Spread/Supp. | +8.39% | +109.32% | +28.10% |
| Support | 1.430 | 0.7405 | 1.210 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ITRM Stock
- Charts Iterum Therapeutics plc